Karen Grinzaid MS/CGC/CCRC
- Department of Human Genetics
Adjunct Associate Professor
- (404) 778-8645
- karen.grinzaid@emory.edu
-
JScreen at Emory University
5115 New Peachtree Road, Suite 301
Atlanta, GA 30341
Overview
Ms. Grinzaid received her master's degree in human genetics from Sarah Lawrence College in 1984 and her bachelor's degree in psychology from Northwestern University in 1982.
Grinzaid was certified by the American Board of Genetic Counseling in 1987 and by the Association of Clinical Research Professionals in 2007.
Since joining the Emory Division of Medical Genetics in 1986, Grinzaid has specialized in multiple program areas including prenatal, pediatric, and adult genetic counseling, newborn screening, lysosomal storage disease clinical care and research, and Jewish genetic disease screening.
She is currently the executive director for JScreen, a national online Jewish genetic disease screening program based out of the Department of Human Genetics. She also serves as an instructor and mentor in Emorys Genetic Counselor Training Program.
Research
My primary research focus over the past several years has been facilitating national access to education, reproductive carrier screening and genetic counseling for high-risk ethnic groups. In July 2019, we launched an Emory IRB-approved pilot study evaluating BRCA-related risks and testing in the Ashkenazi Jewish (AJ) community in Atlanta. The study is evaluating whether the well-established Ashkenazi Jewish carrier rate of 1 in 40 applies to AJs with no significant personal and/or family history of related cancers, whether this rate applies to those with full versus partial AJ ancestry, the adequacy of screening for three common mutations in BRCA1/2 versus sequencing of the genes, and the impact of an education and screening campaign. Our goal was to enroll 500 participants within one year. We are also conducting a related survey study entitled "Attitudes about genetic testing for hereditary cancer risk among JScreen participants" with Georgetown University. JScreen plans to launch cancer genetic testing nationally in 2020.
Academic Appointment
- Adjunct Associate Professor, Emory University
Education
Degrees
- BA in Psychology from Northwestern University
- MS in Human Genetics from Sarah Lawrence College
Research
Publications
-
Benefits, limitations, and impacts of reproductive carrier screening and telehealth-based genetic counseling for individuals with an increased chance to have a child with agenetic condition.
J Genet Couns Volume: 34 Page(s): e70002
06/01/2025 Authors: Hardy MW; Bruder K; Rosen A; Ali N; Laney D; Moore RH; Rose E; Sun Y; Grinzaid KA -
Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study.
Public Health Genomics Page(s): 1 - 14
08/09/2022 Authors: Rose E; Hardy MW; Gates R; Stanislaw C; Meisel J; Grinzaid KA -
Evaluating the experiences of individuals with personal health risks identified through expanded carrier screening.
J Genet Couns Volume: 31 Page(s): 598 - 607
06/01/2022 Authors: Brown EM; Grinzaid KA; Ali N; Mehta N; Hardy MW -
Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.
J Community Genet Volume: 13 Page(s): 281 - 292
06/01/2022 Authors: Hardy MW; Peshkin BN; Rose E; Ladd MK; Binion S; Tynan M; McBride CM; Grinzaid KA; Schwartz MD -
Genetic counseling for personal health risk in individuals heterozygous for hypophosphatasia variants identified through expanded carrier screening
Volume: 24 Page(s): S356 - S356
03/21/2022 Authors: Hardy M; Rose E; Goldberg E; Yerxa C; Grinzaid K -
Patients' reactions and follow-up testing decisions related to Tay-Sachs (HEXA) variants of uncertain significance results.
J Genet Couns Volume: 28 Page(s): 738 - 749
08/01/2019 Authors: Yip T; Grinzaid KA; Bellcross C; Moore RH; Page PZ; Hardy MW -
Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.
Mol Genet Genomic Med Volume: 7 Page(s): e836
08/01/2019 Authors: Cecchi AC; Vengoechea ES; Kaseniit KE; Hardy MW; Kiger LA; Mehta N; Haque IS; Moyer K; Page PZ; Muzzey D -
Reclassification of common variants of unknown significance in the hexosaminidase A gene: Implications for Tay-Sachs disease carrier screening
Volume: 123 Page(s): S133 - S133
02/01/2018 Authors: Smith ED; Grinzaid KA; Hardy M; Cecchi A; Kiger L; Muzzey D; Kaseniit E; Moyer K -
Implementation of a Carrier Screening Program in a High-Risk Undergraduate Student Population Using Digital Marketing, Online Education, and Telehealth.
Public Health Genomics Volume: 21 Page(s): 67 - 76
01/01/2018 Authors: Hardy MW; Kener HJ; Grinzaid KA -
Impact of education and the facilitation of carrier screening in a population at increased risk for lysosomal diseases
Volume: 120 Page(s): S58 - S59
01/01/2017 Authors: Grinzaid KA